| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9382 |
| Human Intestinal Absorption | HIA+ | 0.9784 |
| Caco-2 Permeability | Caco2+ | 0.7004 |
| P-glycoprotein Substrate | Substrate | 0.9146 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5744 |
| Inhibitor | 0.5786 |
| Renal Organic Cation Transporter | Inhibitor | 0.5456 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4630 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8333 |
| CYP450 2D6 Substrate | Substrate | 0.8265 |
| CYP450 3A4 Substrate | Substrate | 0.7756 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8816 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8585 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6282 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7855 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7875 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8723 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8131 |
| Non-inhibitor | 0.6056 |
| AMES Toxicity | Non AMES toxic | 0.7498 |
| Carcinogens | Non-carcinogens | 0.9437 |
| Fish Toxicity | High FHMT | 0.9714 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9692 |
| Honey Bee Toxicity | High HBT | 0.5544 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.5958 |
| Carcinogenicity (Three-class) | Non-required | 0.5934 |